Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children-Reference-Cited by-同舟云学术

Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children

Published:2021-09-02 Issue:12 Volume:56 Page:2981-2989
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Pincez Thomas^ORCID,Santiago Raoul^ORCID,Bittencourt Henrique^ORCID,Louis Isabelle,Bilodeau Mélanie^ORCID,Rouette Alexandre^ORCID,Jouan Loubna^ORCID,Landry Josette-Renée^ORCID,Couture Françoise,Richer Johanne,Teira Pierre,Duval Michel^ORCID,Cellot Sonia

Funder

Fondation Charles Bruneau, fellowship grant

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01408-5.pdf

Reference53 articles.

1. Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–52.

2. Schrappe M, Hunger SP, Pui C-H, Saha V, Gaynon PS, Baruchel A, et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med. 2012;366:1371–81.

3. Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, et al. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood. 2010;116:4007–15.